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ABSTRACT: Leucas martinicensis is a medicinal plant used in traditional medicine to treat convulsions 
and epilepsy. The present study was to evaluate the anticonvulsant and sedative effects of the aqueous 
leave extract of L. martinicensis in Wistar rats.  The anticonvulsant activities of L. martinicensis (50, 
100, 200 or 400 mg/kg i.p.) were evaluated using maximal electroshock seizure (MES) - and strychnine 
(STR) -induced seizure models while the sedative properties were evaluated using the diazepam-
induced sleep model in Wistar rats. The 400 mg/kg of the extract protected rats (100%) against 
seizures in both models while at 200 mg/kg seizure protection (100%) was only in STR model. There 
was a significant (p<0.05) delay in the onset and reduction in the duration of seizure in the two m odels 
in unprotected rats. L. martinicensis exerted sedative effect by significantly reducing the onset (sleep 
latency) and increasing the total duration of sleep induced by diazepam. These results suggest that 
aqueous extract of L. martinicensis may possess anticonvulsant and sedative properties that might 
show efficacy against primary generalised seizures and secondarily generalised tonic -clonic seizures in 
humans. It also lends pharmacological credence to the use of the plant in traditional medicine for the 
management of epilepsy and convulsions. 
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INTRODUCTION  
Epilepsy is one of the commonest chronic 
neurological disorders which are estimated to affect 
60 million people or more worldwide (Alexopoulous, 
2013). It is a heterogeneous syndrome often 
characterized by recurrent and spontaneous seizures 
(Sasa, 2006). Several attempts have been made to 
treat/manage this disorder using antiepileptic drugs 
(AED). The current therapeutic treatment of epilepsy 
with modern AED is associated with side effects, 
dose related toxicity, pharmacoresistance and 
teratogenic effects (Loscher and Schmidt, 2002; 
Scharfman, 2007). A lot of people who are in search 
of safer alternative result to the use of traditional or 
complementary/alternative medicine in the treatment 
of this disorder. 
 
Medicinal plants have been utilized by 80% of the 
population of the third world countries to treat various 
ailments (WHO, 1996). Evidence based traditional 
medicine has shown that some of these herbs are 
potent in alleviating many health conditions including 
epilepsy. Plants that have been proven to possess 
anticonvulsant activities include Carissa edulis (Ya’u 
et al., 2008), Cotyledon orbiculata (Amabeoku et al., 
2007), Evolvulus alsinoides (Abubakar et al., 2013) 
and Ficus religiosa (Patil et al., 2011). Many others 
such as Leucas martinicensis have been used 
empirically to treat convulsions and epilepsy without 
scientific proof of efficacy. 
 
The genus Leucas comprises about 80 species 
(Hedge, 1990). Leucas martinicensis (Jacq.) R. Br. 
(Lamiaceae) is a native plant to South America, West 
Indies and may be native or introduced in Africa  
(Muhammad et al., 2012). It is commonly known as 
Whitewort or mosquito plant and ‘Bunsurun fadama’ 
in the Northern part of Nigeria. L. martinicensis is an 
erect strong aromatic annual herb growing up to 1.5m 
high. It is widely distributed in the tropical parts of 
Africa, Arabia, Asia and America (Muhammad et al., 
2012). The decoction of the leaves of this plant is 
used in traditional medicine to treat many ailments 
(kidney disorders, rheumatism inflammations, cough, 
diarrhoea, fevers, skin rashes, epilepsy and 
convulsions) (Minja, 1999; Agra et al., 2007).  
 
Pharmacological studies revealed in Leucas species 
antimalaria (Valsaraj et al., 1997), anti-inflammatory 
(Reddy et al., 1986) and antidiabetic  (Saha et al., 
1998) activities. Phytochemical analysis of this plant 
showed the presence of alkaloids, saponins, 
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flavonoids and glycosides (Ezeh et al., 2013). The 
present study was to evaluate the anticonvulsant and 
sedative properties of aqueous leave extract of L. 




Fresh leaves of L. martinicensis were collected in 
Kara local market of Sokoto in the Month of March. A 
voucher specimen (020) was authenticated and 
deposited in the Taxonomy unit of the Department of 
Botany, Usmanu Danfodiyo University, Sokoto. The 
leaves were washed, air dried to a constant weight 
and pulverized mechanically into a dried powder. 380 
g of the dry powder were macerated in 2.5 L of 
distilled water for 24 h. The mixture was occasionally 
stirred throughout the period. Filtration was carried 
out initially with muslin cloth and finally with Whatman 
filter paper. The filtrate was evaporated in a hot air 
oven at 45oC with a percentage yield of 4.27%w/w. 
The resultant dry powder was suspended in distilled 
water and subsequently administered to the rats 
according to their dose group. 
 
Drugs and Chemicals 
Strychnine was obtained from Sigma Chemical, USA 
while diazepam was supplied by Hoffmann-La Roche 
(Roche Pharmaceuticals, 340 Kingsland Street 
Nutley, New Jersey 07110). 
 
Experimental Animals 
Adult male Wistar rats of 10-12 weeks old (170–180 
g) which was obtained from the animal facility centre 
of our university were used for the experiment. The 
animals were housed under controlled conditions at a 
temperature of 25±2 ◦C, with 12 h light/dark cycles. 
Food and water were provided ad libitum. The care 
and handling of the animals were in accordance with 
the Animal Research Regulation 1985-2010 and the 
Organisation for Economic Development (OECD) 
guidelines on good laboratory practice (Organisation 
for Economic Development, 2008). 
 
Anticonvulsant Studies 
Maximal Electroshock (MES) Model 
Rats were divided in six groups of 6 rats and received 
various treatments. Group I received distilled water. 
Groups II to V (test groups) were administered with 4 
doses (50, 100, 200, 400 mg/kg i.p.) of the plants 
extract. Group VI (reference group) was treated with 
diazepam at a dose of 3 mg/kg i.p. After 30 mins of 
the treatment, hind limb tonic extension (HLTE) of 
rats were induced by passing alternating electrical 
current (60 Hz, 30 mA, 0.2 s) through eye electrodes 
(Ngo Bum et al., 2009; Ngo Bum et al., 2001). The 
animals that did not show HLTE within 10 mins were 
considered protected. The number of rats protected 
was determined in each dose group. The latency and 
duration of seizures were also determined in the 
unprotected rats using a stop watch. 
 
Strychnine (STR) test 
Six groups of 6 rats were treated 30 mins before the 
administration of STR (3 mg/kg i.p.) as discussed 
previously. They were placed in individual cages and 
observed. Latency and duration of convulsion, 
percentage of animals protected and percentage of 
death within 24 h were noted (Yemitan and Adeyemi, 
2005; Czuczwar and Frey, 1986).  The animals that 
did not show clonic or tonic convulsion within 10 mins 




Diazepam-induced sleep in rats 
Rats were divided in five groups of 6 rats each and 
treated with distilled water as the control group and 
plant extract comprising 4 groups (50, 100, 200 or 
400 mg/kg i.p. group). Thirty minutes after, all the 
groups received diazepam (5 mg/kg i.p.). The time 
from the injection up to the loss of the righting reflex 
is recorded as sleeping latency and the time between 
the loss and voluntary recovery of the righting reflex 
is recorded as the duration of sleep using a stop 
watch (Wambebe, 1985). 
 
Statistical Analysis 
All results are presented as mean ± standard error of 
mean (SEM). They were analysed using graph pad 
prism version 6 software. One-way analysis of 
variance (ANOVA) was used to compare all groups 
followed by Students t-test. Differences were 
considered significant at p < 0.05. 
 
 RESULTS 
The extract of L. martinicensis, like the diazepam, 
completely protected rats at the dose of 400 mg/kg 
against HLTE caused by MES induced seizures 
(Table 1). In the unprotected rats, the latency of 
seizure (sec) was significantly (p<0.05) higher than 
the control at all dose levels.  The duration of seizure 
(min) was significant only in the 200 and 400 mg/kg 
dose levels. There were no deaths recorded.  
 
In the STR- induced seizure model (Table 2), 
complete protection of rats was observed with L. 
martinicensis at doses of 200 and 400 mg/kg. A 
significant (p<0.05) increase in latency and reduction 
in duration of seizure were observed in 50 and 100 
mg/kg. In this model, all animals died within 24 h.  
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In the diazepam-induced sleep test, the extract of L. 
martinicensis in a dose related manner, significantly 
(p<0.05) decreased the onset of sleep time (sleep 
latency) at all dose levels (Fig 1) and increased the 
duration of sleep (Fig 2). 
 
Table 1: The effect of L. martinicensis on the convulsions induced in rats by MES 
Group/Doses of  
L. martinicensis 
% of Protection  Latency of 
seizure(s) 
Duration of Seizure 
(mins) 
% of Survival  
50 mg/kg 0 4.5±0.39a 5.33±0.30 100 
100 mg/kg 0 4.8±0.64a 3.83±0.28a 100 
200 mg/kg 0 5.0±0.66a 2.5±0.39a 100 
400 mg/kg 100a - - 100 
Diazepam (3 mg/kg) 100 - - 100 
Distilled water 0 1.8±0.37 5.35±0.45 100 
Data are mean ± SEM, n=6 per dose, a p<0.05 vs control (Distilled water) 
 
 
Table 2: The effect of L. martinicensis on the convulsions induced in rats by Strychnine 
Group/Doses of  
L. martinicensis 
% of Protection  Latency of 
seizure(s) 
Duration of Seizure 
(mins) 
% of Survival 
within 24 h 
50 mg/kg 0 4.6±0.45b 4.65±0.22b 0 
100 mg/kg 0 6.0±0.33b 3.12±0.14b 0 
200 mg/kg 100b - - 0 
400 mg/kg 100b - - 0 
Diazepam (3 mg/kg) 100 - - 0 
Distilled water 0 2.0±0.33 7.17±0.37 0 
Data are mean ± SEM, n=6 per dose, bp<0.05 vs control (Distilled water) 
\  
Figure 1. Effect of L. martinicensis on sleep latency time induced by diazepam (5 mg/kg).  
The results are presented as mean±S.E.M.  n= 6 per dose, cp<0.05 as compared to control. Lm= L. martinicensis (mg/kg). 
 
Figure 2. Effect of L. martinicensis on duration of sleep induced by diazepam (5 mg/kg). 



























































The present study demonstrated the anticonvulsant 
effects of the aqueous leave extract of Leucas 
martinicensis in both electrically and chemically 
induced seizures in rats. The extract exhibited dose-
dependent protection in the MES and STR tests. 
Further, like diazepam, the extract provided 100% 
protection at 200 and 400 mg/kg in the STR and 400 
mg/kg in MES models. However, in lower doses than 
these, the extract failed to protect the animals in the 
two models.  Nevertheless, in unprotected animals, L. 
martinicensis significantly increased seizure latency 
and reduced duration of seizure compared with the 
control group in all models at all tested doses. 
 
Electrically induced seizures have proven to be 
effective against generalized tonic–clonic and partial 
seizures in humans (Delgado and Remers, 1998). In 
MES-induced seizure, L. martinicensis not only 
protected the animals against seizures but also 
increased the onset and reduced the duration of 
seizures in the unprotected rats. Protection against 
HLTE in MES-induced seizures suggests the ability of 
a substance to prevent the spread of seizure 
discharge from the epileptic focus in the brain. It also 
implies the suppression of generalized tonic–clonic 
and partial seizures (White, 1997; Hosseinzadeh and 
Parvardeh, 2004). The ability of the extract to inhibit 
the HLTE in MES induced seizure suggests 
anticonvulsant activity for the management of 
generalized tonic–clonic and partial seizures. 
 
Chemically induced seizure was used to further study 
the anticonvulsant properties of this extract. STR acts 
as a selective competitive antagonist that blocks the 
inhibitory effect of glycine at all glycine receptors 
(Parmar and Shiv, 2006). The inhibition of STR-
induced seizures by L. martinicensis suggests 
seizure suppression by acting on glycine inhibitory 
mechanisms and the involvement of glycine 
receptors. Thus, the observed protection of diazepam 
or L. martinicensis in the STR test is presumably 
mediated through the glycinergic pathway. The 
extract showed more protection in STR test than in 
MES this suggests that the extract may contain 
constituents which not only act through glycinergic 
pathway but may be able to control generalised tonic-
clonic and partial seizures. 
 
Benzodiazepines exhibit sedative effects by 
potentiating GABA-ergic pathways (Rang et al., 
1999).  L. martinicensis in a dose related manner 
potentiated the sedative ability of diazepam by 
decreasing sleep latency and increasing duration of 
sleep. This suggests that the extract could contain 
some components that activate the benzodiazepine 
and/or GABA receptor sites in the GABAA receptor 
complex. Decrease in sleep latency and increase in 
duration of sleep are also central inhibitory effects 
through the stimulation of the CNS inhibitory 
pathways (Akah et al., 2007). 
 
CONCLUSION 
The results obtained in the present study suggest that 
Leucas martinicensis may possess anticonvulsant 
and sedative activities and thus partly lend 
pharmacological credence to the use of the plant 
extract in traditional medicine in the treatment of 
epilepsy and convulsions. Further studies are 
required to isolate and characterise the active 
compounds in the extract. 
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